PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
BTEE.L vs. GNOG.L
Performance
Return for Risk
Dividends
Drawdowns
Volatility

BTEE.L vs. GNOG.L

Last updated Apr 2, 2026

Compare and contrast key facts about iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) and Global X Genomics & Biotechnology UCITS ETF (GNOG.L).

BTEE.L and GNOG.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BTEE.L is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Mar 5, 2018. GNOG.L is a passively managed fund by Global X that tracks the performance of the MSCI World/Health Care NR USD. It was launched on Nov 2, 2021. Both BTEE.L and GNOG.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

BTEE.L vs. GNOG.L - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) and Global X Genomics & Biotechnology UCITS ETF (GNOG.L). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

BTEE.L vs. GNOG.L - Yearly Performance Comparison

2026 (YTD)20252024202320222021
BTEE.L
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)		3.29%32.82%-1.69%5.84%-11.88%-5.96%
GNOG.L
Global X Genomics & Biotechnology UCITS ETF		-2.27%20.48%-18.36%-6.67%-37.25%-10.07%
Different Trading Currencies

BTEE.L is traded in USD, while GNOG.L is traded in GBP. To make them comparable, the GNOG.L values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, BTEE.L achieves a 3.29% return, which is significantly higher than GNOG.L's -2.27% return.

BTEE.L

1D
2.25%
1M
-1.36%
YTD
3.29%
6M
17.25%
1Y
39.34%
3Y*
13.16%
5Y*
4.62%
10Y*
—

GNOG.L

1D
3.97%
1M
-5.08%
YTD
-2.27%
6M
13.26%
1Y
41.05%
3Y*
-2.46%
5Y*
—
10Y*
—
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)

Global X Genomics & Biotechnology UCITS ETF

Often compared with BTEE.L:
BTEE.L vs. VOOBTEE.L vs. NBTK.DEBTEE.L vs. DOCT.LBTEE.L vs. WBIO.LBTEE.L vs. BIGT.LBTEE.L vs. WHCE.LBTEE.L vs. SBIO.L
Often compared with GNOG.L:
GNOG.L vs. DOCT.LGNOG.L vs. XGES.LGNOG.L vs. SBIO.LGNOG.L vs. XSHC.LGNOG.L vs. BTEK.LGNOG.L vs. HEAW.LGNOG.L vs. BIGT.L

BTEE.L vs. GNOG.L - Expense Ratio Comparison

BTEE.L has a 0.35% expense ratio, which is lower than GNOG.L's 0.50% expense ratio.

GNOG.L
Global X Genomics & Biotechnology UCITS ETF
BTEE.L
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)

Return for Risk

BTEE.L vs. GNOG.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
BTEE.L
BTEE.L Risk / Return Rank: 8686
Overall Rank
BTEE.L Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
BTEE.L Sortino Ratio Rank: 8585
Sortino Ratio Rank
BTEE.L Omega Ratio Rank: 7777
Omega Ratio Rank
BTEE.L Calmar Ratio Rank: 8989
Calmar Ratio Rank
BTEE.L Martin Ratio Rank: 9393
Martin Ratio Rank
GNOG.L
GNOG.L Risk / Return Rank: 6464
Overall Rank
GNOG.L Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
GNOG.L Sortino Ratio Rank: 6767
Sortino Ratio Rank
GNOG.L Omega Ratio Rank: 5454
Omega Ratio Rank
GNOG.L Calmar Ratio Rank: 7373
Calmar Ratio Rank
GNOG.L Martin Ratio Rank: 5959
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BTEE.L vs. GNOG.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) and Global X Genomics & Biotechnology UCITS ETF (GNOG.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

BTEE.LGNOG.LDifference

Sharpe ratio

Return per unit of total volatility

1.77

1.33

+0.44

Sortino ratio

Return per unit of downside risk

2.38

1.91

+0.47

Omega ratio

Gain probability vs. loss probability

1.31

1.24

+0.07

Calmar ratio

Return relative to maximum drawdown

3.20

2.19

+1.01

Martin ratio

Return relative to average drawdown

14.39

7.05

+7.35

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BTEE.L vs. GNOG.L - Sharpe Ratio Comparison

The current BTEE.L Sharpe Ratio is 1.77, which is higher than the GNOG.L Sharpe Ratio of 1.33. The chart below compares the historical Sharpe Ratios of BTEE.L and GNOG.L, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading graphics...

Sharpe Ratios by Period

BTEE.LGNOG.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.77

1.33

+0.44

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.22

—

—

Sharpe Ratio (All Time)

Calculated using the full available price history

0.30

-0.44

+0.74

Correlation

The correlation between BTEE.L and GNOG.L is 0.83, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Dividends

BTEE.L vs. GNOG.L - Dividend Comparison

BTEE.L's dividend yield for the trailing twelve months is around 0.36%, while GNOG.L has not paid dividends to shareholders.

TTM20252024202320222021202020192018
BTEE.L
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)		0.36%0.37%0.46%0.39%0.44%0.25%0.17%0.14%0.07%
GNOG.L
Global X Genomics & Biotechnology UCITS ETF		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

BTEE.L vs. GNOG.L - Drawdown Comparison

The maximum BTEE.L drawdown since its inception was -38.29%, smaller than the maximum GNOG.L drawdown of -69.29%. Use the drawdown chart below to compare losses from any high point for BTEE.L and GNOG.L.

Loading graphics...

Drawdown Indicators

BTEE.LGNOG.LDifference

Max Drawdown

Largest peak-to-trough decline

-38.29%

-67.50%

+29.21%

Max Drawdown (1Y)

Largest decline over 1 year

-14.02%

-17.16%

+3.14%

Max Drawdown (5Y)

Largest decline over 5 years

-38.29%

—

—

Current Drawdown

Current decline from peak

-2.70%

-48.74%

+46.04%

Average Drawdown

Average peak-to-trough decline

-13.78%

-44.07%

+30.29%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.81%

5.75%

-2.94%

Volatility

BTEE.L vs. GNOG.L - Volatility Comparison

The current volatility for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) is 7.46%, while Global X Genomics & Biotechnology UCITS ETF (GNOG.L) has a volatility of 10.36%. This indicates that BTEE.L experiences smaller price fluctuations and is considered to be less risky than GNOG.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading graphics...

Volatility by Period

BTEE.LGNOG.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.46%

10.36%

-2.90%

Volatility (6M)

Calculated over the trailing 6-month period

14.21%

21.69%

-7.48%

Volatility (1Y)

Calculated over the trailing 1-year period

22.17%

30.73%

-8.56%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.18%

32.81%

-11.63%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.50%

32.81%

-10.31%